% | $
Quotes you view appear here for quick access.

ArQule Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • pharmainvestor11 pharmainvestor11 Jun 4, 2012 4:40 PM Flag

    Bad Time to Take the Kids to the 4th of July Party!

    Typical BS from spin-artists:

    "ArQule Inc. reported statistically significant increased overall survival in some liver cancer patients who were treated with its experimental drug tivantinib.

    ArQule faced criticism going into the ASCO meeting after releasing some data that showed a relatively small magnitude benefit when looking at time to progression and progression-free survival rates.

    The overall survival benefit, however, is "much more robust and clinically meaningful" in this set of data, said RBC Capital."

1.45+0.01(+0.69%)Aug 26 4:00 PMEDT